SOD1 and amyotrophic lateral sclerosis: Several gene therapies for SOD1 mutant ALS have been developed to silence SOD1 mRNA expression, delivered in the form of antisense oligonucleotides (ASOs) or adeno-associated virus (AAV) vectors carrying short hairpin RNA (shRNA) [13, 14].